News Agency

BioCity Announces Enrollment Completion of the IgA Nephropathy (IgAN) Cohort in the Randomized, Placebo-controlled Phase II Clinical Trial of the ETA Receptor Antagonist SC0062

  • Written by PR Newswire

WUXI, China, Feb. 25, 2024 /PRNewswire/ -- BioCity Biopharma is pleased to announce the completion of enrollment of all 120 participants in the IgA nephropathy (IgAN) cohort in a randomized, double-blind, placebo-controlled Phase 2 clinical study of the novel, oral endothelin A (ETA)-receptor selective antagonist SC0062, currently...

Read more: BioCity Announces Enrollment Completion of the IgA Nephropathy (IgAN) Cohort in the Randomized,...

The Ultimate Guide to Pet Grooming Services in NSW

In the heart of New South Wales (NSW), where the bustling city life meets the serene landscapes, the pet grooming industry is not just thriving; it's revolutionising the way pet parents pamper their furry family members.  With a profound understanding that... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion